Change language dansk English suomi svenska

Generate Estimates Confirm Cancel Hide empty rows Show hidden rows DummyText

Tandlægeselskabet Godt Smil Slagelse ApS Estimate generation in progress, please wait... 0%

Quicksearch from your own companies XBRLDenmark Analyst: XBRLDenmark

Loading... Loading... Loading... Loading...   Loading...

1000.0 Bankruptcy Risk  2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024 2024/12 2025e N/A 2026e N/A Bankruptcy risk for industry   0.5% 0.5% 0.5% 0.5% 0.5% 0.5% 0.5% 0.5%   Bankruptcy risk   3.6% 2.6% 2.3% 3.0% 2.6% 3.0% 10.3% 10.1%   Credit score (0-100)   54 61 64 57 60 58 24 24   Credit rating   BBB BBB BBB BBB BBB BBB BB BB   Credit limit (kDKK)   0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0   How are these values calculated?   View the automatically generated explanation of bankruptcy risk 1000.0 Income statement (kDKK)  2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024 2024/12 2025e N/A 2026e N/A Net sales   0 0 0 0 0 0 0 0   Gross profit   10,589 10,522 12,074 13,461 11,716 11,393 0.0 0.0   EBITDA   1,832 1,520 2,458 3,209 2,315 2,130 0.0 0.0   EBIT   1,290 1,037 1,974 2,705 1,690 1,487 0.0 0.0   Pre-tax profit (PTP)   1,135.3 941.6 1,893.5 2,992.9 1,643.8 1,459.4 0.0 0.0   Net earnings   892.7 741.5 1,476.8 2,332.6 1,279.1 1,134.9 0.0 0.0   Pre-tax profit without non-rec. items   1,135 942 1,894 2,993 1,644 1,459 0.0 0.0     See the entire income statement 1000.0 Balance sheet (kDKK)  2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024 2024/12 2025e N/A 2026e N/A Tangible assets total   3,129 2,898 2,453 2,017 1,978 1,372 0.0 0.0   Shareholders equity total   300 1,041 1,788 2,121 1,650 1,535 1,410 1,410   Interest-bearing liabilities   295 310 1,261 914 198 125 0.0 0.0   Balance sheet total (assets)   5,503 5,946 6,312 5,055 4,664 3,485 1,410 1,410   Net Debt   -20.4 -998 -1,399 -746 -1,001 -924 -1,410 -1,410     See the entire balance sheet 1000.0 Volume  2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024 2024/12 2025e N/A 2026e N/A Net sales   0 0 0 0 0 0 0 0   Net sales growth   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Gross profit   10,589 10,522 12,074 13,461 11,716 11,393 0.0 0.0   Gross profit growth   51.7% -0.6% 14.7% 11.5% -13.0% -2.8% -100.0% 0.0%   Employees   16 16 16 17 16 14 0 0   Employee growth %   6.7% 0.0% 0.0% 6.3% -5.9% -12.5% -100.0% 0.0%   Employee expenses   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   Balance sheet total (assets)   5,503 5,946 6,312 5,055 4,664 3,485 1,410 1,410   Balance sheet change%   -5.9% 8.1% 6.2% -19.9% -7.7% -25.3% -59.5% 0.0%   Added value   1,832.0 1,520.4 2,458.1 3,209.0 2,194.1 2,130.2 0.0 0.0   Added value %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Investments   -1,054 -715 -929 -940 -664 -1,248 -1,372 0   Net sales trend   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   EBIT trend   1.0 2.0 3.0 4.0 5.0 5.0 0.0 0.0   1000.0 Profitability  2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024 2024/12 2025e N/A 2026e N/A EBITDA %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   EBIT %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   EBIT to gross profit (%)   12.2% 9.9% 16.3% 20.1% 14.4% 13.1% 0.0% 0.0%   Net Earnings %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Profit before depreciation and extraordinary items %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Pre tax profit less extraordinaries %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   ROA %   22.4% 19.0% 32.5% 54.4% 34.9% 36.7% 0.0% 0.0%   ROI %   41.9% 30.5% 55.2% 93.0% 63.1% 77.3% 0.0% 0.0%   ROE %   29.1% 110.6% 104.4% 119.3% 67.8% 71.3% 0.0% 0.0%   1000.0 Solidity  2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024 2024/12 2025e N/A 2026e N/A Equity ratio %   5.8% 18.8% 30.1% 43.8% 36.7% 44.6% 100.0% 100.0%   Relative indebtedness %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Relative net indebtedness %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Net int. bear. debt to EBITDA, %   -1.1% -65.7% -56.9% -23.3% -43.3% -43.4% 0.0% 0.0%   Gearing %   98.4% 29.8% 70.5% 43.1% 12.0% 8.1% 0.0% 0.0%   Net interest   0 0 0 0 0 0 0 0   Financing costs %   69.3% 48.3% 12.5% 9.1% 9.5% 22.3% 0.0% 0.0%   1000.0 Liquidity  2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024 2024/12 2025e N/A 2026e N/A Quick Ratio   0.6 1.0 1.1 1.5 1.1 1.2 0.0 0.0   Current Ratio   0.7 1.0 1.1 1.5 1.2 1.4 0.0 0.0   Cash and cash equivalent   315.6 1,308.5 2,659.6 1,660.6 1,199.1 1,048.6 0.0 0.0   1000.0 Capital use efficiency  2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024 2024/12 2025e N/A 2026e N/A Trade debtors turnover (days)   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   Trade creditors turnover (days)   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   Current assets / Net sales %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Net working capital   -814.1 -9.1 408.8 1,012.2 384.8 588.4 0.0 0.0   Net working capital %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   1000.0 Employee efficiency  2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024 2024/12 2025e N/A 2026e N/A Net sales / employee   0 0 0 0 0 0 0 0   Added value / employee   115 95 154 189 137 152 0 0   Employee expenses / employee   0 0 0 0 0 0 0 0   EBITDA / employee   115 95 154 189 145 152 0 0   EBIT / employee   81 65 123 159 106 106 0 0   Net earnings / employee   56 46 92 137 80 81 0 0